HPV Vaccine Available on Vidal Health Digital Platform
“`html
HPV Vaccine Now Recommended for All Adolescents, Irrespective of Gender
Table of Contents
Updated recommendations from teh CDC expand HPV vaccine eligibility, aiming to significantly reduce cancer rates.
What is HPV and Why is Vaccination Crucial?
Human papillomavirus (HPV) is a common virus that can cause a variety of cancers. It’s spread through skin-to-skin contact, most often during sexual activity. While often asymptomatic and clearing on its own, persistent HPV infections can lead to cancer.
Previously, the HPV vaccine was primarily recommended for girls and young women to prevent cervical cancer. Though, research has shown that HPV also causes cancers in men, including anal, penile, and oropharyngeal (throat) cancers.The CDC’s updated recommendations reflect this understanding.
The HPV vaccine is most effective when administered before the start of sexual activity,ideally between ages 11 and 12. Though,the CDC now recommends vaccination through age 26,and adults aged 27 through 45 may also benefit from vaccination after discussing it with their healthcare provider.
The CDC’s Updated Recommendations: A Detailed Look
The CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend the HPV vaccine for all adolescents, regardless of gender, starting at age 11 or 12. The proposal is based on a comprehensive review of the latest scientific evidence.
Key changes include:
- Gender-Neutral Recommendation: The vaccine is now recommended for all adolescents, eliminating the previous gender-specific focus.
- Expanded Age Range: While the ideal age remains 11-12, vaccination is recommended through age 26.
- Consideration for Adults 27-45: Adults in this age range may choose to get vaccinated after discussing the benefits and risks with their doctor.
- 9vHPV Vaccine: The 9-valent HPV vaccine (9vHPV), which protects against nine HPV types, is the recommended vaccine.
The CDC emphasizes that the HPV vaccine is safe and effective. Common side effects are mild, such as pain or swelling at the injection site.
Impact on Cancer Rates: What the Data Shows
The HPV vaccine has already had a important impact on HPV infection rates and precancerous cervical lesions. As the vaccine was introduced in 2006, rates of HPV infections have decreased by 86% among vaccinated girls.
| Cancer Type | Estimated HPV-Attributable Cases (U.S., 2018) |
|---|---|
| Cervical Cancer | 3,400 |
| Anal Cancer |